treatment

LAAO (left atrial appendage occlusion)

In patients with atrial fibrillation (AF, irregular heart rhythm) and an elevated risk of stroke who are unable to take oral anticoagulation (blood thinners) to reduce stroke risk, LAAO can be considered to reduce bleeding risk and provide stroke risk reduction without the requirement for long term oral anticoagulation.

Point 2

What is the left atrial appendage and why is it a problem?

In patients with AF at elevated stroke risk, the out pouching of the left atrium - the left atrial appendage - is a very common site for the development of thrombosis (blood clot) that can move through the arterial system to the brain, blocking a vital brain artery to cause a stroke. Usually oral anticoagulation medication substantially reduces the risk of this occurring and is the currently recommended treatment for most patients with AF at an elevated risk of stroke.

Point 1

Why would you need LAAO?

Several scenario’s exist where LAAO may be recommended by Prof. Shand. Firstly you may have had major bleeding whilst taking anticoagulation (blood thinners) and other medical specialists have recommended that these are discontinued leaving you at an elevated risk of stroke. Alternatively, you may have had an AF related stroke despite taking anticoagulation tablets and additional stroke risk reduction is required. Finally, some patients do not wish to take anticoagulation tablets in the long term and want to explore other avenues of stroke risk reduction.

Frequently asked questions

The procedure is minimally invasive and usually performed under general anaesthetic. A plastic tube is inserted into the femoral vein (large vein in the groin) and after carefully crossing into the lefthand side of the heart, the LAAO device is positioned using Echo and X-ray guidance. Typically it takes 25-40 minutes to perform.

There is a 1-2% risk of a major complication. Complications include but are not limited to major bleeding, stroke and complications related to anaesthesia and transoesophageal echo (a specialised Echo test). Very rarely (1:500-1:1000 cases) the LAAO device can embolise (move) from its intended position and require retrieval. This may require surgery to remove the device.

You will remain in hospital with monitoring of your heart electrical function and have an echo as well as general observation overnight. Most patients are allowed home the day following implantation.

For up to 3 months following the procedure you will require low dose oral anticoagulation or antiplatelet medication whilst the device settles in. At 3 months you will have a TOE and if this is satisfactory, in most cases blood thinning medication will be reduced or stopped. Prof Shand will typically review you following the 3 month TOE and answer any questions you may have.

Related Services

Registered Provider

VHI healthcare registered Cardiologist Dublin
Irish life registered cardiologist
Laya Healthcare registered provider

Get in touch for a consultation